Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage trials.
The final, formatted version of the article will be published soon. The initial electrocardiogram (ECG) of a 5-month-old infant with complex congenital heart disease (pulmonary valvular stenosis, ...
Learn how ECG noise filtering that adapts to noise type improved QT and QRS accuracy and supports more reliable cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback